News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
553,031 Results
Type
Article (46658)
Company Profile (119)
Press Release (506243)
Multimedia
Podcasts (145)
Webinars (19)
Section
Business (146028)
Career Advice (2421)
Deals (28236)
Drug Delivery (142)
Drug Development (68633)
Employer Resources (158)
FDA (15991)
Job Trends (12066)
News (266065)
Policy (29929)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2323)
Academic (1)
Accelerated approval (37)
Adcomms (36)
Allergies (140)
Alliances (36228)
ALS (165)
Alzheimer's disease (1718)
Antibody-drug conjugate (ADC) (319)
Approvals (16136)
Artificial intelligence (507)
Autoimmune disease (167)
Automation (36)
Bankruptcy (312)
Best Places to Work (9194)
BIOSECURE Act (23)
Biosimilars (195)
Biotechnology (69)
Bladder cancer (160)
Brain cancer (55)
Breast cancer (594)
Cancer (4595)
Cardiovascular disease (418)
Career advice (2048)
Career pathing (39)
CAR-T (261)
CDC (64)
Celiac Disease (1)
Cell therapy (729)
Cervical cancer (35)
Clinical research (58989)
Collaboration (1509)
Company closure (4)
Compensation (1178)
Complete response letters (77)
COVID-19 (2723)
CRISPR (92)
C-suite (807)
Cystic fibrosis (141)
Data (5877)
Decentralized trials (2)
Denatured (33)
Depression (150)
Diabetes (484)
Diagnostics (5565)
Digital health (38)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (224)
Drug pricing (221)
Drug shortages (33)
Duchenne muscular dystrophy (241)
Earnings (62501)
Editorial (68)
Employer branding (20)
Employer resources (142)
Events (82221)
Executive appointments (902)
FDA (19104)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (20)
Funding (1287)
Gene editing (198)
Generative AI (44)
Gene therapy (612)
GLP-1 (1069)
Government (4208)
Grass and pollen (8)
Guidances (377)
Healthcare (14910)
HIV (63)
Huntington's disease (50)
IgA nephropathy (87)
Immunology and inflammation (293)
Immuno-oncology (63)
Indications (109)
Infectious disease (2995)
Inflammatory bowel disease (189)
Inflation Reduction Act (14)
Influenza (112)
Intellectual property (242)
Interviews (454)
IPO (14200)
IRA (58)
Job creations (3175)
Job search strategy (1672)
JPM (67)
Kidney cancer (17)
Labor market (84)
Layoffs (619)
Leadership (41)
Legal (7020)
Liver cancer (90)
Longevity (13)
Lung cancer (610)
Lymphoma (360)
Machine learning (40)
Management (52)
Manufacturing (749)
MASH (170)
Medical device (11603)
Medtech (11651)
Mergers & acquisitions (15037)
Metabolic disorders (1327)
Multiple sclerosis (148)
NASH (22)
Neurodegenerative disease (329)
Neuropsychiatric disorders (100)
Neuroscience (2943)
Neurotech (1)
NextGen: Class of 2026 (4997)
Non-profit (3197)
Now hiring (31)
Obesity (666)
Opinion (283)
Ovarian cancer (154)
Pain (191)
Pancreatic cancer (223)
Parkinson's disease (279)
Partnered (26)
Patents (489)
Patient recruitment (469)
Peanut (55)
People (44342)
Pharmaceutical (33)
Pharmacy benefit managers (32)
Phase 1 (17697)
Phase 2 (25531)
Phase 3 (20909)
Pipeline (5188)
Policy (340)
Postmarket research (2209)
Preclinical (7164)
Press Release (28)
Prostate cancer (242)
Psychedelics (57)
Radiopharmaceuticals (249)
Rare diseases (901)
Real estate (4305)
Recruiting (65)
Regulatory (23274)
Reports (41)
Research institute (2120)
Resumes & cover letters (404)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (155)
Series A (218)
Series B (177)
Service/supplier (8)
Sickle cell disease (98)
Special edition (26)
Spinal muscular atrophy (139)
Sponsored (47)
Startups (2793)
State (1)
Stomach cancer (21)
Supply chain (105)
Tariffs (101)
The Weekly (111)
Vaccines (1111)
Venture capital (97)
Weight loss (467)
Women's health (76)
Worklife (22)
Date
Today (31)
Last 7 days (550)
Last 30 days (2099)
Last 365 days (28130)
2026 (3790)
2025 (28410)
2024 (31414)
2023 (35008)
2022 (45107)
2021 (48560)
2020 (45575)
2019 (36290)
2018 (27445)
2017 (27872)
2016 (25851)
2015 (28023)
2014 (21828)
2013 (17849)
2012 (19027)
2011 (19416)
2010 (17561)
Location
Africa (688)
Alabama (68)
Alaska (6)
Arizona (233)
Arkansas (10)
Asia (32398)
Australia (5675)
California (10543)
Canada (2544)
China (921)
Colorado (410)
Connecticut (466)
Delaware (309)
Europe (79829)
Florida (1600)
Georgia (322)
Hawaii (4)
Idaho (39)
Illinois (754)
India (58)
Indiana (430)
Iowa (22)
Japan (413)
Kansas (106)
Kentucky (27)
Louisiana (19)
Maine (73)
Maryland (1301)
Massachusetts (7627)
Michigan (268)
Minnesota (557)
Mississippi (5)
Missouri (118)
Montana (12)
Nebraska (22)
Nevada (111)
New Hampshire (61)
New Jersey (2832)
New Mexico (15)
New York (2730)
North Carolina (1363)
North Dakota (7)
Northern California (5247)
Ohio (283)
Oklahoma (15)
Oregon (34)
Pennsylvania (2026)
Puerto Rico (18)
Rhode Island (32)
South America (1045)
South Carolina (65)
South Dakota (1)
Southern California (4100)
Tennessee (152)
Texas (1566)
United States (36859)
Utah (268)
Virginia (246)
Washington D.C. (73)
Washington State (836)
West Virginia (4)
Wisconsin (113)
Wyoming (1)
553,031 Results for "bavarian nordic a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
February 12, 2026
·
6 min read
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - February 2, 2026
February 2, 2026
·
2 min read
Press Releases
Bavarian Nordic Launches Planned Share Buy-Back Program
January 7, 2026
·
2 min read
Press Releases
Bavarian Nordic Receives USD 22.5 Million Contract for its Mpox and Smallpox Vaccine from the Government of Canada
February 18, 2026
·
2 min read
Press Releases
Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil
January 26, 2026
·
5 min read
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - January 19, 2026
January 20, 2026
·
2 min read
Press Releases
Bavarian Nordic Announces Changes to the Board of Directors
November 14, 2025
·
2 min read
Press Releases
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
December 17, 2025
·
1 min read
Press Releases
Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees
December 19, 2025
·
3 min read
Press Releases
Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen
November 27, 2025
·
1 min read
1 of 55,304
Next
